Benzothiazole is a heterocyclic organic compound that serves as a fundamental structural scaffold in the development of various pharmaceutical agents, including those with antimicrobial, anticancer, and… Read more
![Chemical structure of 3-Chloro-5-methyl-1,2, 4-triazole [3,4-b][1,3] benzothiazole](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1356928-66-9-3-Chloro-5-methyl-12-4-triazole-34-b13-benzothiazole.png&w=3840&q=75)
![Chemical structure of 6-Thiocyanatobenzo[d]thiazol-2-amine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F7170-77-6-6-Thiocyanatobenzodthiazol-2-amine.png&w=3840&q=75)
![Chemical structure of Benzo[d]thiazole-2-sulfonic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F941-57-1-Benzodthiazole-2-sulfonic-Acid.png&w=3840&q=75)





Benzothiazole is a heterocyclic organic compound that serves as a fundamental structural scaffold in the development of various pharmaceutical agents, including those with antimicrobial, anticancer, and anti-inflammatory properties. Because this chemical framework is integral to a wide array of drug candidates, analytical laboratories require high-quality reference standards for rigorous impurity profiling and method validation. This category encompasses benzothiazole, along with its related derivatives, process impurities, and stable isotope-labelled compounds. These materials are essential for identifying trace contaminants, ensuring regulatory compliance, and conducting precise quantitative analysis during the research, development, and quality control stages of drug manufacturing. By utilizing these characterized reference materials, researchers can accurately monitor the stability and integrity of benzothiazole-based formulations throughout the pharmaceutical development lifecycle.